# A Study to Evaluate Plasma Gelsolin in Healthy Volunteers

> **NCT05789745** · PHASE1 · COMPLETED · sponsor: **BioAegis Therapeutics Inc.** · enrollment: 32 (actual)

## Conditions studied

- Volunteers
- Healthy

## Interventions

- **DRUG:** Recombinant human plasma gelsolin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05789745
- **Lead sponsor:** BioAegis Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-14
- **Primary completion:** 2023-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789745, "A Study to Evaluate Plasma Gelsolin in Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05789745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*